The patents-based pharmaceutical development process: rationale, problems, and potential reforms.
@article{Barton2005ThePP, title={The patents-based pharmaceutical development process: rationale, problems, and potential reforms.}, author={J. Barton and E. Emanuel}, journal={JAMA}, year={2005}, volume={294 16}, pages={ 2075-82 } }
The pharmaceutical industry is facing substantial criticism from many directions, including financial barriers to access to drugs in both developed and developing countries, high profits, spending on advertising and marketing, and other issues. Underlying these criticisms are fundamental questions about the value of the current patent-based drug development system. Six major problems with the patent system are (1) recovery of research costs by patent monopoly reduces access to drugs; (2) market… CONTINUE READING
Topics from this paper
90 Citations
Value of pharmaceuticals: ensuring the future of research and development.
- Medicine
- Journal of the American Pharmacists Association : JAPhA
- 2006
- 9
How Efficient is the Patent System? A General Appraisal and an Application to the Pharmaceutical Sector
- Engineering, Business
- 2008
- 3
- PDF
Australian Pharmaceutical Policy: Price Control, Equity, and Drug Innovation in Australia
- Business, Medicine
- Journal of public health policy
- 2008
- 17
A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness.
- Economics, Medicine
- Health policy
- 2011
- 23
Late-stage pharmaceutical R&D and pricing policies under two-stage regulation.
- Economics, Medicine
- Journal of health economics
- 2016
- 11
- PDF
Access to medicines, market failure and market intervention: A tale of two regimes
- Economics, Medicine
- Global public health
- 2012
- 22
- PDF
Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis.
- Economics, Medicine
- Health policy
- 2007
- 66
- PDF
References
SHOWING 1-10 OF 19 REFERENCES
The price of innovation: new estimates of drug development costs.
- Economics, Medicine
- Journal of health economics
- 2003
- 3,837
- PDF
The pharmaceutical industry--prices and progress.
- Medicine
- The New England journal of medicine
- 2004
- 125
- PDF
Rare diseases, drug development, and AIDS: the impact of the Orphan Drug Act.
- Medicine
- The Milbank quarterly
- 1995
- 29
- PDF